Ignite Creation Date:
2024-05-05 @ 11:32 AM
Last Modification Date:
2024-10-26 @ 9:09 AM
Study NCT ID:
NCT00070564
Status:
ACTIVE_NOT_RECRUITING
Last Update Posted:
2024-04-15
First Post:
2003-10-03
Brief Title:
S0221 Adjuvant Doxorubicin Cyclophosphamide and Paclitaxel in Treating Patients With Breast Cancer
Sponsor:
SWOG Cancer Research Network
Organization:
SWOG Cancer Research Network
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Breast Cancer |
Keywords:
| Name | View |
|---|---|
| progesterone receptor-positive breast cancer | View |
| stage II breast cancer | View |
| stage IA breast cancer | View |
| stage IB breast cancer | View |
| stage IIIC breast cancer | View |
| male breast cancer | View |
| HER2-positive breast cancer | View |
| estrogen receptor-negative breast cancer | View |
| estrogen receptor-positive breast cancer | View |
| progesterone receptor-negative breast cancer | View |